Phase I Safety and Tolerability Study of Birinapant in Chronic Hepatitis B
Clinical trial NCT02288208 · TERMINATED
Trial details
- NCT number
- NCT02288208
- Sponsor
- TetraLogic Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2015-05-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.